Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

6
Just The Numbers: Comparing Mid-Continent And Rockies Refiners

2018-07-20 seekingalpha
Refiners' stock prices are typically seasonally strong in the summer, reflecting demand. These and refining margins themselves appear softer now due to higher feedstock oil prices.
PBF BRK.A HFC PSX CVRR ANDV MPC

7
Schlumberger (SLB) Q2 Earnings Beat, Revenues Miss Estimates

2018-07-20 zacks
Oilfield service giant Schlumberger Limited’s (SLB - Free Report) second-quarter 2018 earnings of 43 cents per share (excluding charges and credits) beat the Zacks Consensus Estimate of 42 cents and improved from the year-ago quarter’s figure of 35 cents.
SLB CVRR SCL SLB OXY

6
Kinder Morgan (KMI) Beats Q2 Earnings and Revenue Estimates

2018-07-19 zacks
Energy infrastructure provider Kinder Morgan Inc. (KMI - Free Report) reported second-quarter 2018 earnings of 21 cents per share from continuing operations, which beat the Zacks Consensus Estimate of 19 cents and improved 50% from 14 cents in the year-ago quarter.
KMI.PRA KML KMI KMI.WS CVRR OXY KMR KMRFZ CVB

10
ConocoPhillips (COP) Releases Update on Alaska Operations

2018-07-18 zacks
ConocoPhillips (COP - Free Report) provided an update on its Alaska operation plans, which are faring well, courtesy of the company’s efforts to lower costs, advance technology and recovery in exploration activities. The company intends to grow by investing in legacy assets and recognizes Alaska as an appropriate destination for this strategy. ConocoPhillips’ legacy assets in Alaska comprise a non-operated interest in the Prudhoe Bay Field, an operated interest in the Kuparuk Field and an operated interest in the Alpine Field/Western North Slope assets.
COP STNY CVRR OXY

2
Bull of the Day: Interactive Corp

2018-07-13 zacks
Founded in 1995, Match Group (MTCH - Free Report) and its flagship product Match.com are far and away the biggest household names in online dating. Growing both organically and through acquisitions, the group now encompasses popular sites and apps across a broad spectrum of potential daters. Match group has 7 million subscribers worldwide and 3 million of them use Tinder - the most profitable segment of Match Group’s business for advertising.
MTCH FB CVRR SAM

0
Why CVR Refining (CVRR) Could Shock the Market Soon

2018-07-12 zacks
It commonly happens in stock investing that investors miss the chance of buying winning stocks that they knew would stand out. Before they take the plunge, others get to know the hidden potential and enter into these stocks, pushing them out of reach.
CVRR

7
Weatherford (WFT) to Divest Land Drilling Rigs to Lower Debt

2018-07-12 zacks
Weatherford International plc’s (WFT - Free Report) subsidiary has inked a definitive agreement to sell its land drilling rig operations in Algeria, Kuwait and Saudi Arabia to ADES International Holding Ltd and also two idle land rigs in Iraq. The company expects to raise $287.5 million from the divestiture. The sale comprises 31 land drilling rigs and related contracts along with 2,300 employees and contract personnel.
LMT MS.PRE MS.PRF MS.PRG MS.PRA MS.PRI MS.PRK WFT ADI CVRR MS OXY

0
CVR Refining to Release 2018 Second Quarter Earnings

2018-07-12 globenewswire
SUGAR LAND, Texas, July 12, 2018 (GLOBE NEWSWIRE) -- CVR Refining, LP (NYSE:CVRR), a refiner and marketer of petroleum fuels, today announced that it will release its 2018 second quarter results on Wednesday, July 25, after the close of New York Stock Exchange trading. Chief Executive Officer Dave Lamp and other executives will host a teleconference call for analysts and investors on July 26 at 1 p.
CVRR DTK

0
CVR Energy to Release 2018 Second Quarter Earnings

2018-07-12 globenewswire
SUGAR LAND, Texas, July 12, 2018 (GLOBE NEWSWIRE) -- CVR Energy, Inc. (NYSE:CVI) today announced that it will release its 2018 second quarter results on Wednesday, July 25, after the close of New York Stock Exchange trading. Chief Executive Officer Dave Lamp and other executives will host a teleconference call for analysts and investors on July 26 at 3 p.m. Eastern.
UAN CVI DTK CVRR

0
Bull of the Day: Bonanza Creek (BCEI)

2018-07-12 zacks
Bonanza Creek Energy, Inc. (BCEI - Free Report) is cashing in on higher crude prices and strong demand. This Zacks Rank #1 (Strong Buy) is expected to see earnings jump nearly 300% in 2018. Bonanza Creek is a small cap exploration and production company headquartered in Denver, Colorado. With a market cap of $720 million, it has operations in the Wattenberg Field in Colorado and the Cotton Valley sands of Southern Arkansas in the Mid-Continent.
LMT CVRR BCEI

7
Update On CVR Refining Ahead Of Q2 Earnings

2018-07-11 seekingalpha
We reveal our forecast for CVRR earnings for the remainder of 2018, including our forecast earnings beat for Q2.
CVRR IEP

1
HollyFrontier to Buy Red Giant Oil, Expand Lubricants Unit

2018-07-11 zacks
HollyFrontier Corporation (HFC - Free Report) recently inked a deal to acquire a private lubricants firm, Red Giant Oil Company. Founded in 1963, Iowa-based Red Giant Oil is one of the largest suppliers of locomotive engine oil in North America. Red Giant produces around 24 million gallons of diesel engine oil annually. The financial details of the acquisition have been kept under wraps. Subject to approvals and satisfactory closing conditions, the deal is set for closure in the third quarter of 2018.
DK HFC CVRR SU SU

0
Bull of the Day: BP plc (BP)

2018-07-11 zacks
Global oil prices rose on Tuesday as concerns related to supply levels continue to mount. A strike in Norway and disruptions in Libya have added to these concerns, while sanctions against Iran and the ongoing Venezuela crisis have devastated inventory. Nevertheless, disciplined oil behemoths like BP plc (BP - Free Report) might actually be able to take advantage of these trends.
CVRR DLPH

6
Here's Why Investors Should Scoop Up BP Stock Right Away

2018-07-11 zacks
A prudent investor keeps adding well-performing stocks when the time is right and sells the risky ones. Strong fundamentals and favorable price performance indicate a stock’s bullish run. BP plc (BP - Free Report) is among the leading integrated energy players in the world. The stock has performed well in the past six months and has the potential to sustain the momentum in the near term. Therefore, if you haven’t taken advantage of the share price appreciation yet, it’s time you add the stock to your portfolio.
SNP SNP CVRR OXY

14
Groupon (GRPN) Reportedly On Lookout For a Potential Buyer

2018-07-09 zacks
Groupon, Inc. (GRPN - Free Report) is searching a prospective buyer, per a Recode report. In the past month, the company’s executives and bankers have been “aggressively” pursuing various public listed companies to bid for Groupon. Recode cited “two people” familiar with the approach as their source. Groupon once boasted a market cap more than $16 billion. The investors’ interest was renewed in the company after it launched a novel website platform of providing daily deals to online consumers.
BABA GRPN GOOGL CVRR

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 12663P107